Apocrine Carcinomas Are a Distinct Subset of Androgen Receptor Positive (AR plus ) Triple Negative Breast Carcinomas (TNBC)

被引：0
|
作者：
Astvatsaturyan, Kristine [1 ]
Yue, Yong [1 ]
Bose, Shikha [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
LABORATORY INVESTIGATION | 2017年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
108
引用
收藏
页码：30A / 30A
页数：1
相关论文
共 50 条
  • [41] Real-life data of antiandrogens (AA) use in metastatic androgen receptor positive triple negative breast cancer (AR plus TNBC): The ATOVAT retrospective French cohort.
    Rhanine, Yasmine
    Bonnefoi, Herve R.
    Goncalves, Anthony
    Debled, Marc
    Le Moulec, Sylvestre
    Bonichon-Lamichhane, Nathalie
    Dubroca-Dehez, Benedicte
    Grellety, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [42] Triple Negative Breast Carcinomas Similarities and Differences With Basal Like Carcinomas
    Lerma, Enrique
    Barnadas, Agusti
    Prat, Jaime
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2009, 17 (06) : 483 - 494
  • [43] Safety and tolerability of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR plus ) triple negative breast cancer.
    Lyons, Tomas
    Gucalp, Ayca
    Arumov, Artavazd
    Patil, Sujata
    Edelweiss, Marcia
    Gorsky, Mila
    Troso-Sandoval, Tiffany A.
    Bromberg, Jacqueline
    Sanford, Rachel Ann
    Iyengar, Neil M.
    Modi, Shanu
    Gupta, Ranju
    Traina, Tiffany A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [44] Heterogeneity of triple-negative breast carcinomas
    Menard, S.
    ONCOLOGIE, 2012, 14 (01) : 28 - 30
  • [45] Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast
    Honma, N
    Takubo, K
    Akiyama, F
    Sawabe, M
    Arai, T
    Younes, M
    Kasumi, F
    Sakamoto, G
    HISTOPATHOLOGY, 2005, 47 (02) : 195 - 201
  • [46] Impact of Progesterone Receptor (PR) and Androgen Receptor (AR) on Aromatase Inhibitor Treated Estrogen Receptor (ER) Positive Metastatic Breast Carcinomas
    Wang, Xi
    Kadambi, Sindhuja
    Eckert-Davis, Laura
    Strawderman, Myla
    Meacham, Philip
    Khatib, Hasan
    Yang, Qi
    Dhakal, Ajay
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 281 - 281
  • [47] Impact of Progesterone Receptor (PR) and Androgen Receptor (AR) on Aromatase Inhibitor Treated Estrogen Receptor (ER) Positive Metastatic Breast Carcinomas
    Wang, Xi
    Kadambi, Sindhuja
    Eckert-Davis, Laura
    Strawderman, Myla
    Meacham, Philip
    Khatib, Hasan
    Yang, Qi
    Dhakal, Ajay
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 281 - 281
  • [48] Immunohistochemical study of androgen receptor in breast carcinomas
    Bayrak, Reyhan
    Yenidunya, Sibel
    VIRCHOWS ARCHIV, 2007, 451 (02) : 294 - 294
  • [49] Prognostic value of androgen receptor expression and molecular alterations in metastatic triple-negative or low hormone receptor breast carcinomas
    Shen, Tiansheng
    Wei, Lai
    Li, Xiaoxian
    Parwani, Anil, V
    Li, Zaibo
    HUMAN PATHOLOGY, 2021, 116 : 73 - 81
  • [50] Invasive apocrine carcinoma of the breast: clinicopathologic features and comprehensive genomic profiling of 18 pure triple-negative apocrine carcinomas
    Sun, Xiangjie
    Zuo, Ke
    Yao, Qianlan
    Zhou, Shuling
    Shui, Ruohong
    Xu, Xiaoli
    Bi, Rui
    Yu, Baohua
    Cheng, Yufan
    Tu, Xiaoyu
    Lu, Hongfen
    Yang, Wentao
    MODERN PATHOLOGY, 2020, 33 (12) : 2473 - 2482
12345